Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice.
Vigário AM, Belnoue E, Grüner AC, Mauduit M, Kayibanda M, Deschemin JC, Marussig M, Snounou G, Mazier D, Gresser I, Rénia L.
J Immunol. 2007 May 15;178(10):6416-25.PMID: 17475871 [PubMed - indexed for MEDLINE]Related articlesFree article